Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-053941
Filing Date
2004-03-30
Accepted
2004-03-30 16:26:58
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE PERIOD ENDED DECEMBER 31, 2003 d10k.htm 10-K 809095
3 SETTLEMENT AGREEMENT dex1052.htm EX-10.52 22329
4 CONSENT OF GRANT THORNTON LLP dex231.htm EX-23.1 1756
5 CONSENT OF KPMG LLP dex232.htm EX-23.2 2433
6 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8425
7 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8398
8 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3367
9 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3349
  Complete submission text file 0001193125-04-053941.txt   861542
Mailing Address 110 LITTLE FALLS RD FAIRFIELD NJ 07004-2193
Business Address 110 LITTLE FALLS RD FAIRFIELD NJ 07004-2193 9738820860
UNIGENE LABORATORIES INC (Filer) CIK: 0000352747 (see all company filings)

EIN.: 222328609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16005 | Film No.: 04701533
SIC: 2833 Medicinal Chemicals & Botanical Products